| Name | (2E)-2-[1-(3,5-Difluoro-2-hydroxyphenyl)ethylidene]-1-(2-methyl-2-propanyl)hydrazinecarbothioamide | 
|---|---|
| Synonyms | 
                                
                                Hydrazinecarbothioamide, 2-[1-(3,5-difluoro-2-hydroxyphenyl)ethylidene]-1-(1,1-dimethylethyl)-, (2E)-
                                
                                
                                 (2E)-2-[1-(3,5-Difluoro-2-hydroxyphenyl)ethylidene]-1-(2-methyl-2-propanyl)hydrazinecarbothioamide  | 
                        
| Description | IMM-02 is a small molecule agonist of mammalian Diaphanous (mDia)-related formins that disrupts diaphanous inhibitory domain (DID) and diaphanous autoregulatory domain (DAD) interaction with IC50 of 99 nM; sufficiently triggers actin assembly and microtubule stabilization, serum response factor-mediated gene expression, cell-cycle arrest, and apoptosis in vitro; slows tumor growth in a mouse xenograft model of colon cancer. | 
|---|---|
| References | References 1. Lash LL, et al. Cancer Res. 2013 Nov 15;73(22):6793-803. 2. Arden JD, et al. Mol Biol Cell. 2015 Nov 1;26(21):3704-18. View Related Products by Target Other Targets | 
| Density | 1.3±0.1 g/cm3 | 
|---|---|
| Boiling Point | 390.4±52.0 °C at 760 mmHg | 
| Molecular Formula | C13H17F2N3OS | 
| Molecular Weight | 301.355 | 
| Flash Point | 189.9±30.7 °C | 
| Exact Mass | 301.106049 | 
| LogP | 3.73 | 
| Vapour Pressure | 0.0±0.9 mmHg at 25°C | 
| Index of Refraction | 1.552 |